Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-07-15
2008-07-15
Henley, III, Raymond J (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S426000, C514S601000, C514S617000, C514S639000, C514S561000, C514S649000
Reexamination Certificate
active
07399776
ABSTRACT:
This invention relates to a method for treating inflammatory diseases or immune diseases, developmental or degenerative diseases, or tissue injuries. The method includes administering to a subject in need thereof an effective amount of one or more compounds of the following formula. Each variable in this formula is defined in the specification.
REFERENCES:
patent: 5252317 (1993-10-01), Keana
patent: 5567411 (1996-10-01), Keana et al.
patent: 5719193 (1998-02-01), Bowlin et al.
patent: 5910513 (1999-06-01), Galey
patent: 2005/0165063 (2005-07-01), Yamazaki et al.
patent: 62129858 (1987-06-01), None
patent: 64-66117 (1989-03-01), None
patent: 1-272568 (1989-10-01), None
patent: 2002-543126 (2002-12-01), None
patent: 3714948 (2005-09-01), None
patent: WO 97/00245 (1997-01-01), None
patent: WO 00/02870 (2000-01-01), None
patent: WO 00/56729 (2000-09-01), None
patent: WO 00/66112 (2000-11-01), None
patent: WO 02/22600 (2002-03-01), None
patent: WO 02/055112 (2002-07-01), None
patent: WO 02/083143 (2002-10-01), None
Wuntz, T.P. et al., J. Med. Chem., vol. 33, No. 6, pp. 1549-1553, 1990.
Mohamadou et al., “Synthesis and Characterisation of Zinc(II) Complexes of Tripodal N7Ligands Involving Pyridine and Amine or Amide Nitrogen Donors. Crystal Structure of a Zine (II) Complex”, J. Chem. Soc., Dalton Trans., 3320-3328, 2001.
Rannard et al., “The Selective Reaction of Primary Amines with Carbonyl Imidazole Containing Compounds: Selective Amide and Carbamate Synthesis”, Org. Lett., 2:2117-2120, 2000.
Xu et al., “Specific Sequestering Agents for the Actinides. 28. Synthesis and Initial evaluation of Multidentate 4-Crabamoyl-3-hydroxy-1-methyl-2(1H)-pyridinone Ligands for in Vivo Plutonium (IV) Chelation”, J. Med. Chem. 38:2606-2614, 1995.
Yu et al., “Study on Antioxidative Succinimide Dispersants,”Chemical Abstracts Service, [Online] XP002452292, Abstract.
Tecilla et al. “Acceleration o p-Nitrophenyl Ester Cleavage by Zn (II)-Organized Molecular Receptors,”Journal of Organic Chemistry, vol. 62, pp. 7621-7628 (1997) XP002452260.
Deroche et al., “A seven-Coordinate Manganese (II) Complex Formed with a Single Tripodal Heptadentate Ligand as a New Superoxide Scavenger,”Journal of the American Chemical Society, vol. 118, No. 19, pp. 4567-4573 (1996) XP002452261.
Chen Hua-Chien
Hakimelahi Gholam Hossein
Huang Ying-Huey
Shia Kak-Shan
Wang Ching-Cheng
Henley, III Raymond J
Occhiuti Rohlicek & Tsao LLP
Taigen Biotechnology
LandOfFree
Polyamine compounds for treating chemokine receptor mediated... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polyamine compounds for treating chemokine receptor mediated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polyamine compounds for treating chemokine receptor mediated... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2762692